Assessment of miR-424-3p mimic capability to sensitize SK-OV-3 and TOV-21G ovarian cancer cells to cisplatin by decreasing the expression of galectin-3, which is an anti-apoptotic protein overexpressed in ovarian cancer and associated with resistance to chemotherapy.
We performed a reverse transfection of miR-424-3p mimic into SK-OV-3 and TOV-21G ovarian cancer cells, followed by Real Time™ RT-PCR analysis of the expression of miR-424-3p and galectin-3 mRNA as well as ELISA assay for galectin-3 protein level. Next, we studied the viability (XTT assay), proliferation (EdU incorporation assay), and apoptosis (ELISA assay) of the both cell lines transfected with the mimic and treated with cisplatin.
We demonstrated that miR-424-3p mimic effectively transfects into SK-OV-3 and TOV-21G ovarian cancer cells in which it significantly suppresses the expression of galectin-3 at the protein level, but not at the mRNA level. Reverse transfection of both cell lines with the mimic, followed by treatment with cisplatin, resulted in a reduction in cell viability and proliferation as well as an increase in the induction of apoptosis.
MiR-424-3p mimic sensitizes SK-OV-3 and TOV-21G ovarian cancer cells to cisplatin by decreasing the expression of galectin-3.
Mahdian-Shakib A, Dorostkar R, Tat M et al (2016) Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer. Biomed Pharmacother 84:592–600. https://doi.org/10.1016/j.biopha.2016.09.087 CrossRef
Kang HG, Kim S, Cho Y et al (2016) Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain. Oncotarget 7:68229–68241
Santos SN, Junqueira MS, Francisco G et al (2016) O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer. Oncotarget 7:83570–83587. https://doi.org/10.18632/oncotarget.13192
Tseng PC, Chen CL, Shan YS, Lin CF (2016) An increase in galectin-3 causes cellular unresponsiveness to IFN-γ-induced signal transduction and growth inhibition in gastric cancer cells. Oncotarget 7:15150–15160. https://doi.org/10.18632/oncotarget.7750
Lu W, Wang J, Yang G et al (2017) Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression. Oncotarget 8:15242–15251. https://doi.org/10.18632/oncotarget.14839
Bin Park G, Kim DJ, Kim YS et al (2015) Silencing of galectin-3 represses osteosarcoma cell migration and invasion through inhibition of FAK/Src/Lyn activation and β-catenin expression and increases susceptibility to chemotherapeutic agents. Int J Oncol 46:185–194. https://doi.org/10.3892/ijo.2014.2721 CrossRef
Cheng YL, Huang WC, Chen CL et al (2011) Increased galectin-3 facilitates leukemia cell survival from apoptotic stimuli. Biochem Biophys Res Commun 412:334–340. https://doi.org/10.1016/j.bbrc.2011.07.099 CrossRef
Ramasamy S, Duraisamy S, Barbashov S et al (2007) The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop. Mol Cell 27:922–1004. https://doi.org/10.1097/OPX.0b013e3182540562.The CrossRef
Chang R, Li X, Mu N et al (2017) MicroRNA expression profiles in non-epithelial ovarian tumors. Int J Oncol 52:55–66. https://doi.org/10.3892/ijo.2017.4200
Zhao K, Chen Y, Yang R et al (2015) MiR-424/322 is downregulated in the semen of patients with severe DNA damage and may regulate sperm DNA damage. Reprod Fertil Dev. https://doi.org/10.1071/rd15052
Bieg D, Sypniewski D, Nowak E, Bednarek I (2018) Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin. Arch Gynecol Obstet. https://doi.org/10.1007/s00404-018-4912-4
Oishi T, Itamochi H, Kigawa J et al (2007) Galectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary. Int J Gynecol Cancer 17:1040–1046. https://doi.org/10.1111/j.1525-1438.2007.00916.x CrossRef
Wongkham S, Junking M, Wongkham C et al (2009) Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma. Cancer Sci 100:2077–2084. https://doi.org/10.1111/j.1349-7006.2009.01304.x CrossRef
Lee YS, Dutta A (2009) MicroRNAs in cancer. Annu Rev Pathol Mech Dis 4:199–227. https://doi.org/10.1146/annurev.pathol.4.110807.092222.micrornas CrossRef
- MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
- Springer Berlin Heidelberg
Neu im Fachgebiet Gynäkologie und Geburtshilfe
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II